UTRF Licensee Announces Positive Phase 2 Clinical Results of VERU-111 for COVID-19

UTRF licensee Veru, Inc. announced today significant potential of VERU-111 in treating COVID-19, both as a broad-spectrum antiviral and an anti-inflammatory agent, which may help prevent effects leading to Acute Respiratory Distress Syndrome. Statistically significant data from the Phase 2 clinical study results show an 81% relative reduction in death or respiratory failure at Day… Read More

UTRF Inventor Spotlight: Matthew Layne

Local partnership results in creation of new solar charging technology for robotic mowers. One University of Tennessee, Knoxville, staff member sought to solve a problem at work and ended up co-inventing a technology with a local solar company that may unlock new possibilities for the future of electrification. Matthew Layne, co-inventor of a patent-pending, solar-powered… Read More